| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef2a6d661df17e57ad3155c24188735 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 |
| filingDate |
1998-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a82535133a8a8fdf7c40c906d6642e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b21de198529dd5969747cdbb789acb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a2fccbf9915adbcd7acbdbc5b023db7 |
| publicationDate |
2002-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2002179573-A |
| titleOfInvention |
Glaucoma treatment and ocular hypertension treatment |
| abstract |
(57) [Problem] An object of the present invention is to create a drug useful for prevention or treatment of glaucoma and ocular hypertension. SOLUTION: Formula (1): The compound represented by represents an excellent intraocular pressure lowering effect, and exhibits an excellent effect as a preventive or therapeutic agent for glaucoma and ocular hypertension. |
| priorityDate |
1998-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |